ROYAL BANK OF CANADA - PROTALIX BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,000
+38.5%
11,139
+71.4%
0.00%
Q2 2023$13,0006,499
+1642.4%
0.00%
Q3 2022$0373
+2386.7%
0.00%
Q2 2022$0150.0%0.00%
Q1 2022$015
-97.0%
0.00%
Q4 2021$0
-100.0%
5000.0%0.00%
Q3 2021$1,000
-50.0%
500
-55.4%
0.00%
Q2 2021$2,000
-33.3%
1,120
+80.6%
0.00%
Q1 2021$3,000
+50.0%
620
+24.0%
0.00%
Q4 2020$2,0000.0%5000.0%0.00%
Q3 2020$2,0000.0%500
-18.0%
0.00%
Q2 2020$2,000
+100.0%
610
-7.7%
0.00%
Q1 2020$1,000
-66.7%
6610.0%0.00%
Q4 2019$3,0006610.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,125,585$9,480,0007.68%
DAFNA Capital Management LLC 1,204,825$5,374,0001.28%
Psagot Value Holdings Ltd. 3,095,741$13,807,0000.31%
Ground Swell Capital, LLC 14,684$65,0000.21%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 445,171$1,985,000,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,591$1,350,0000.02%
Phoenix Holdings Ltd. 244,113$1,089,0000.02%
Virtu Financial LLC 27,744$124,0000.01%
D.A. DAVIDSON & CO. 130,700$583,0000.01%
Schonfeld Strategic Advisors LLC 89,278$399,0000.01%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders